Injectable nanocatalytic implants with minimally invasive scleral fixation for retinal protection against redox imbalance-mediated injury
Year: 2026
Type: article
Abstract: Oxidative stress is a common upstream mechanism in chronic retinal degeneration, including age-related macular degeneration, diabetic retinopathy, and light-induced retinal injury. However, antioxidant therapy for the posterior segment remains underdeveloped and is further limited by ocular delivery barriers and finite drug-release kinetics. Here, we developed an injectable cerium oxide nanoparticle (CeNP)-embedded nanocatalytic implant designed to provide antioxidant activity within the vitreous cavity and protect the retina. CeNPs were immobilized within a biocompatible polymer matrix to preserve their Ce 3+ /Ce 4+ redox cycling and enzyme-mimetic reactive oxygen species (ROS) scavenging activities. The implant was fabricated for needle-based intravitreal implantation and integrated with a suture for flange-based scleral fixation. The implants successfully retained scavenging activities against hydrogen peroxide, superoxide, and hydroxyl radicals, while effectively reducing NO-derived nitrite levels. They demonstrated excellent cytocompatibility, preventing oxidative cell death and decreasing inflammatory cytokine secretion in vitro . In ex vivo porcine and in vivo rat eyes, the implants were easily delivered and stably fixed. Furthermore, in a rat model of oxidative retinal degeneration, the implant preserved retinal structure and electroretinographic (ERG) responses while mitigating DNA damage and inflammation. Ultimately, this minimally invasive, scleral-fixated implant provides a material-based platform for retinal protection against oxidative stress.
Source: Journal of Nanobiotechnology
Language: English
Subfield: Materials Chemistry
Field: Materials Science
Domain: Physical Sciences
Open Access status: gold
Estimated APC paid: $3,790
OpenAlex ID: W7237358706
FWCI:
Cites:
Cited by:
Related to:
